EUVIMEDEUVIMED entdecken
Crossref

Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer

Wei Ni, Mingzhu Zhang, Yueni Mo, Wei Du, Hui Liu, Zhaosong Wang, Yanfen Cui, He Zhang, Zhiyong Wang, Liming Liu, Hui Guo, Ruifang Niu und 2 weitere

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01690-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Wei Ni und 13 weiteren Autor:innen. Beteiligte Einrichtung: Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Macrophages, Doxorubicin, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Changjiang Scholars and Innovative Research Team, Tianjin Medical University Cancer Institute and Hospital Foundation of Seed Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have demonstrated that the combination of photodynamic therapy, photothermal therapy and chemotherapy is highly effective in treating hepatocellular carcinoma (HCC). However, the clinical application of this approach has been hindered by the lack of efficient and low-toxicity drug delivery platforms. To address this issue, we developed a novel biomimetic nanocarrier platform named ZID@RM, which utilizes ZIF8 functional nanoparticles encapsulated with macrophage membrane and loaded with indocyanine green and doxorubicin. The bionic nanocarrier platform has good biocompatibility, reducing the risk of rapid clearance by macrophages and improving the targeting ability for HCC cells. Under the dual regulation of acidity and infrared light, ZID@RM stimulated the generation of abundant reactive oxygen species within HCC cells, induced tumor cell pyroptosis and promoted the release of damage-associated molecular patterns to induce immune responses. In the future, this technology platform has the potential to provide personalized and improved healthcare by using patients' own macrophage membranes to create an efficient drug delivery system for tumor therapy.Graphical abstract Scheme 1 Schematic representation of the synthesis of a biomimetic nanomedicine delivery platform (ZID@RM) and its application in tumor imaging-guided combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsMacrophagesDoxorubicinCarcinoma, HepatocellularBiomimetic MaterialsNanoparticlesDrug CarriersHumansAnimalsIndocyanine GreenMiceCell Line, TumorReactive Oxygen SpeciesRAW 264.7 CellsCombined Modality Therapy

Stichwörter der Autor:innen

Biomimetic nanocarrierCombination therapyHepatocellular carcinomaImmune activationMacrophage

Substanzen

Indocyanine GreenDoxorubicinDrug CarriersReactive Oxygen Species

Autor:innen und Institutionen

  • Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
  • Key Laboratory of Cancer Prevention and Therapy, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, 300060, China.
  • Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
  • Department of Immunology, Biochemistry and Molecular Biology, Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianj…
  • Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China. feizhang03@tmu.edu.cn.
  • Key Laboratory of Cancer Prevention and Therapy, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin, 300060, China. feizhang03@tmu.edu.cn.

ORCID-Profile: Ran Tian

Förderung

  • National Natural Science Foundation of China
  • Changjiang Scholars and Innovative Research Team
  • Tianjin Medical University Cancer Institute and Hospital Foundation of Seed Project
  • Tianjin Research Innovation Project for Postgraduate Students

Zitieren

APA

Ni, W., Zhang, M., Mo, Y., Du, W., Liu, H., Wang, Z., Cui, Y., Zhang, H., Wang, Z., Liu, L., Guo, H., Niu, R., Zhang, F., & Tian, R. (2025). Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01690-y

Vancouver

Ni W, Zhang M, Mo Y, Du W, Liu H, Wang Z, et al. Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01690-y

BibTeX
@article{Ni2025,
  author = {Ni, Wei and Zhang, Mingzhu and Mo, Yueni and Du, Wei and Liu, Hui and Wang, Zhaosong and Cui, Yanfen and Zhang, He and Wang, Zhiyong and Liu, Liming and Guo, Hui and Niu, Ruifang and Zhang, Fei and Tian, Ran},
  title = {Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and combination therapy in liver cancer},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01690-y}
}
Kostenlos starten →